---
title: "Innovative drug concept stocks are repeatedly active, Thalys has three consecutive limit-ups"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/247058101.md"
description: "Thalys has gained three consecutive trading limits, while Sinocelltech, Microchip Biotech, Science Sun Pharm, Changchun High-tech, and Sinobioway Medicine have all risen over 5%. Additionally, Huahai Pharmaceutical, Jolly, Hotgen, and others have followed suit. In terms of news, the National Healthcare Security Administration and the National Health Commission recently jointly issued \"Several Measures to Support the High-Quality Development of Innovative Drugs,\" proposing 16 measures in 5 areas, emphasizing full-chain support for the research and development, market access, hospital use, and diversified payment of innovative drugs"
datetime: "2025-07-03T01:42:31.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/247058101.md)
  - [en](https://longbridge.com/en/news/247058101.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/247058101.md)
generator: "portal-rs"
---

# Innovative drug concept stocks are repeatedly active, Thalys has three consecutive limit-ups

Thalys has hit the limit up for three consecutive trading days, while Sinocelltech, Microchip Biotech, Science Sun Pharm, Changchun High-tech, and Sinobioway Medicine have all risen over 5%. Huahai Pharmaceutical, Jolly, Hotgen, and others have also followed suit. In terms of news, the National Healthcare Security Administration and the National Health Commission recently jointly issued "Several Measures to Support the High-Quality Development of Innovative Drugs," proposing 16 measures in 5 areas, emphasizing full-chain support for the research and development, access, hospital use, and diversified payment of innovative drugs

### Related Stocks

- [300485.CN](https://longbridge.com/en/quote/300485.CN.md)
- [603716.CN](https://longbridge.com/en/quote/603716.CN.md)
- [688520.CN](https://longbridge.com/en/quote/688520.CN.md)
- [002581.CN](https://longbridge.com/en/quote/002581.CN.md)
- [688068.CN](https://longbridge.com/en/quote/688068.CN.md)
- [300181.CN](https://longbridge.com/en/quote/300181.CN.md)
- [688321.CN](https://longbridge.com/en/quote/688321.CN.md)
- [600521.CN](https://longbridge.com/en/quote/600521.CN.md)
- [000661.CN](https://longbridge.com/en/quote/000661.CN.md)

## Related News & Research

- [Livzon Pharma buys 3.5% Xinbeijiang Pharma stake for RMB 106.7 million](https://longbridge.com/en/news/296601614.md)
- [Oura exploring how its ring could detect brain hemorrhages after Bill Ackman suggests it could have helped his daughter](https://longbridge.com/en/news/296658401.md)
- [HENGRUI PHARMA  1H26 Net Profit Rises 0.3% YoY to RMB4.465 Billion; Shares Now Down Over 7%](https://longbridge.com/en/news/296422700.md)
- [CANSINOBIO  Tetanus Vaccine New Drug Application Approved](https://longbridge.com/en/news/296498620.md)
- [Innova Captab Revises FY26 Accounts and Clears Baddi Plant Expansion](https://longbridge.com/en/news/296661728.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**